As of June 21, 2025, Together Pharma Ltd (TGTR.TA) reports a ROE (Return on Equity) of -3.52%.
ROE (Return on Equity) measures how well a company generates profits from shareholders' investments, indicating equity efficiency.
Historical Trend of Together Pharma Ltd's ROE (Return on Equity)
Over recent years, Together Pharma Ltd's ROE (Return on Equity) has shown significant volatility. The table below summarizes the historical values:
| Date | ROE (Return on Equity) |
|---|---|
| 2024-12-31 | -3.52% |
| 2023-12-31 | 7869.48% |
| 2022-12-31 | -66.78% |
| 2021-12-31 | 86.28% |
| 2020-12-31 | 140.62% |
This gradual decrease highlights how Together Pharma Ltd manages its efficiency in generating profits from shareholders' equity over time.
Comparing Together Pharma Ltd's ROE (Return on Equity) to Peers
To better understand Together Pharma Ltd's position, it's useful to compare its ROE (Return on Equity) against industry peers. Below are selected comparisons:
| Company | ROE (Return on Equity) |
|---|---|
| Together Pharma Ltd (TGTR.TA) | -3.52% |
| Geniee Inc (6562.T) | 24.78% |
| Bengo4.com Inc (6027.T) | 19.30% |
| Meitu Inc (1357.HK) | 16.02% |
| i-mobile Co Ltd (6535.T) | 15.49% |
| Invigor Group Ltd (IVO.AX) | 11.57% |
Compared to its competitors, Together Pharma Ltd's ROE (Return on Equity) is about average compared to peers, reflecting standard industry returns on equity investment.